论文部分内容阅读
2014年1月23日,英国血液学标准委员会(British Committee for Standards in Haematology,BCSH)发布了最新《BCSH预防新生儿溶血病抗-D免疫球蛋白应用指南》(BCSH Guideline for the Use of Anti-D Immunoglobulin for the Prevention of Haemolytic Disease of the Fetus and Newborn)[1](以下简称《指南》),为使用抗-D免疫球蛋白(anti-D immunoglobulin,抗-D Ig)预防Rh D血型阴性(以下简称D-)孕产妇D致敏和由此导致的新生儿溶血病(hemolytic disease of the fe tus and newborn,HDN)提出了详尽的推荐意见。该《指南》将
On January 23, 2014, the British Committee for Standards in Haematology (BCSH) released the latest “BCSH Guideline for the Use of Anti-D Immunoglobulin Guidelines for the Prevention of Neonatal Hemolytic Disease” D Immunoglobulin for the Prevention of Haemolytic Disease of the Fetus and Newborn [1] (hereinafter referred to as the “Guide”) for the prevention of Rh D blood group negative (anti-D immunoglobulin, anti- Hereinafter referred to as D-) maternal D allergen and the resulting hemolytic disease of the feces and newborn (HDN) made detailed recommendations. The “guide” will be